Genomica, S.A.U. products

Is an in vitro diagnostics product line for the detection and genotyping of different types of human Papillomavirus (HPV) by means of multiplex PCR followed by visualization in low-density arrays, based on CLART® Technology.

Designed for automatic reading, analysis and interpretation of CLART®-based diagnostic tests. Suitable for all GENOMICA IVD assays. Allows testing from 1 up to 96 samples per run. User friendly and intuitive graphical interface.

Allows the fully automation of the visualization step, thus considerably reducing the hands-on time required by the process, as well as the intra-assay variability. It’s compacted size and the flexibility in the amount of samples to process (from 4 up to 96 samples simultaneously), point it as the ideal tool for every middle-high throughput laboratory.

CLART® HPV4 offers full screening 35 genotypes: High Risk (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68A-68B), Probable High Risk (26, 53, 73, 82) and Low risk (6, 11, 40, 42, 43, 44, 54, 61, 62, 71, 70, 72, 81, 83, 84, 85, 89).

CLART HPV4s offers the detection of High Risk Genotypes (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68A-68B).

CLART HPV3 detects 49 genotypes including High Risk (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68), Low Risk (6, 11, 40, 42, 43, 44, 54, 61, 62, 70, 71, 72, 81, 83, 84, 85, 89), and indeterminate risk genotypes targeted for investigation (34, 64, 67, 69 74, 86, 87, 97, 101, 102, 103, 106, 150, 151).

CLART® STDs CLART® STDs is an in vitro diagnostic product for the detection and identification of bacteria, fungi and parasites causing infections in the human urogenital tract. The technique used is based on our CLART® technology, and involves multiplex PCR amplification of the sample and subsequent visualization on low density arrays.